Showing 92 of 92on this page. Filters & sort apply to loaded results; URL updates for sharing.92 of 92 on this page
Syndax Pharmaceuticals Logo im PNG-Format mit transparentem Hintergrund
Syndax Pharmaceuticals Collaborates with Genentech to examine ...
Syndax Pharmaceuticals (SNDX) Stock Price, News & Analysis
Syndax Pharma releases new data from its AUGMENT-101 trial of Revuforj ...
Syndax Pharmaceuticals (NASDAQ:SNDX) Hits New 52-Week High - What's Next?
Syndax Pharmaceuticals Nears Critical Regulatory Milestone - Stocks Today
Syndax Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call ...
Syndax Pharmaceuticals logo in transparent PNG and vectorized SVG formats
Syndax Pharmaceuticals - ASCO Annual 2024
Logo de Syndax Pharmaceuticals au format PNG transparent
Jan 2023 Cancer Treatment Highlights: Syndax Pharmaceuticals ...
SNDX | Syndax Pharmaceuticals, Inc. Stock Data, Price & News
Syndax Pharmaceuticals, Inc. (SNDX) Stock Price, News, Quote & History ...
Incyte and Syndax Receives US FDA Approval for Niktimvo (axatilimab ...
Syndax Pharmaceuticals (SNDX) Company Profile, History, Products & Services
Goldman Sachs Initiates Coverage of Syndax Pharmaceuticals (SNDX) with ...
Breaking Down Syndax Pharmaceuticals, Inc. (SNDX): Key Insights for ...
Syndax Pharmaceuticals Hits Day Low at $13.03 Amid Price ...
Syndax Pharmaceuticals (SNDX) ENCORE 601 Update - Slideshow (NASDAQ ...
Exploring Syndax Pharmaceuticals, Inc. (SNDX): Who s Buying and Why ...
Buy Syndax Pharmaceuticals Stock – SNDX Stock Quote Today & Investment ...
Syndax Pharmaceuticals on LinkedIn: Learn More About Syndax ...
Syndax (SNDX) Gains FDA Priority Review for Leukemia Treatment
Syndax Pharmaceuticals: The Story Brightens (NASDAQ:SNDX) | Seeking Alpha
Syndax Pharmaceuticals: Time to Buy or Sell?
Pipeline - Syndax
Syndax Pharmaceuticals Treatment Pipeline | Syndax Pharmaceuticals - Syndax
syndax treatment image
FDA approves Syndax drug revuforj for advanced leukemia | STAT
Syndax Pharmaceuticals, Inc. (SNDX) SWOT Analysis – DCFmodeling.com
SYNDAX PHARMACEUTICALS: Announces FDA Clearance of IND Application for ...
Syndax Pharmaceuticals Inc Company Profile - Overview - GlobalData
Syndax Pharmaceuticals: A Dual-Driven Catalyst for Long-Term ...
Syndax gets FDA okay for first-in-class leukaemia drug | pharmaphorum
Syndax Launches Groundbreaking Revuforj for Leukemia Patients ...
Syndax Pharmaceuticals (SNDX): Valuation in Focus After Revumenib Wins ...
Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA
Syndax Pharmaceuticals: A Biotech on the Rise in Q1 2025
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals Careers | Levels.fyi
Big Gain For Syndax Pharmaceuticals, Inc. | Stocktreats
Syndax Pharmaceuticals, Inc. (SNDX): This Small-Cap Healthcare Stock Is ...
Syndax Announces Positive Revuforj Data in Acute Leukemias from ...
Syndax Pharmaceuticals Issues New Inducement Grants Amidst Ongoing ...
Syndax Pharmaceuticals, Inc. 2017 Q2 - Results - Earnings Call Slides ...
Careers - Syndax
Syndax (SNDX) Surges 40.5% in 3 Months • BioTech Health X
Syndax Pharmaceuticals: Employee Benefits and Perks | Glassdoor
Syndax Pharmaceuticals announces clinical collaboration with Genentech
Syndax Pharmaceuticals and Royalty Pharma Enter into $350M Royalty ...
#newsalert | Syndax Pharmaceuticals
Syndax Pharmaceuticals Inc. (SNDX) Gains Attention with Promising Drug ...
Home - Syndax
Syndax enters funding agreement with Royalty Pharma for Niktimvo
Syndax Pharmaceuticals names Daphne Karydas as new CFO | hrnxt.com
Syndax and Incyte collaborate on axatilimab for cGVHD | The Pharmaletter
Syndax Pharmaceuticals Highlights Revuforj, Niktimvo Sales Surge and ...
Syndax Pharmaceuticals Salaries | Levels.fyi
Syndax Pharmaceuticals, Inc. (SNDX) ANSOFF Matrix Analysis ...
Syndax Completes $115 Million Follow-On Offering | Baird
Syndax Pharmaceuticals Inc Stock Price ($SNDX), Quote & News | eToro
Delos Capital | Finding, Funding and Fostering Global Innovation
December 22 2021
SNDX (Syndax Pharmaceuticals, Inc.) – Technical Charts and Market Data ...
Acute Leukemia Drug Revuforj Wins FDA Approval, Second Approval for ...
Microbiology FDA Approves Syndax’s Revuforj® for Refractory Acute ...
FDA approves Syndax’s Revuforj to treat leukaemia
US FDA approves Syndax's blood cancer drug, ETPharma
Syndax: Oversold Pharma Likely To Benefit From Drug Approvals (SNDX ...
臨牀階段生物制藥公司：Syndax Pharmaceuticals(SNDX) – 美股投資指南
7 Health Care Stocks to Buy for Robust Returns | Kiplinger
Life Science ERP Software | NetSuite
Elevation Oncology - 2025 Company Profile, Team, Funding, Competitors ...
Syndax-logo
超6亿美元！因赛特携手Syndax开发治疗慢性移植物抗宿主病和其他纤维化疾病的单抗疗法 药明康德 内容团队编辑9月27日，Syndax ...
Syndax, 특발성 폐 섬유증 신약후보물질 미FDA '희귀 의약품' 지정 대식세포를 타겟으로 하는 항체 신약후보물질 ...
Syndax制药简介-Syndax制药成立时间|总部|股票代码-排行榜123网
